Loading...
Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study
PURPOSE: A phase II study of bevacizumab (BVZ) plus irinotecan (CPT-11) was conducted in children with recurrent malignant glioma (MG) and intrinsic brainstem glioma (BSG). PATIENTS AND METHODS: Eligible patients received two doses of BVZ intravenously (10 mg/kg) 2 weeks apart and then BVZ plus CPT-...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
American Society of Clinical Oncology
2010
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2903337/ https://ncbi.nlm.nih.gov/pubmed/20479404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.8789 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|